Clinical Trial Update: Long-term Safety and Efficacy Extension Trial of Bimatoprost SR [Phase 3]

View source ↗

Summary

Phase 3 long-term safety and efficacy extension study of Bimatoprost SR has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Bimatoprost SR (bimatoprost)

Snippet

Sponsor: AbbVie | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED